CDTX vs LOW · rev $1.3M vs P/E 18, rev $86.29B
Cidara Therapeutics Inc (CDTX) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
CDTX currently screens at market cap $6.96B. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the CDTX and LOW stock pages for the full models.
Not investment advice.